When does Parkinson's disease begin? from prodromal disease to motor signs

Revue Neurologique

Volumn 168, Issue 11, 2012, Pages 809-814

  Meissner, W G ^a,b,c  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

Author keywords

Braak staging; Non motor signs; Premotor disease

Indexed keywords

DOPAMINE; NEUROPROTECTIVE AGENT;

ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN DEGENERATION; DENERVATION; DOPAMINERGIC TRANSMISSION; HUMAN; MOTOR DYSFUNCTION; OLFACTORY BULB; OLFACTORY NERVE DISEASE; PARKINSON DISEASE; REM SLEEP; RISK FACTOR; SLEEP DISORDER;

EID: 84869085667     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2012.07.004     Document Type: Review

References (54)

1. R.D. Abbott, H. Petrovitch, L.R. White, K.H. Masaki, C.M. Tanner, and J.D. Curb Frequency of bowel movements and the future risk of Parkinson's disease Neurology 57 2001 456 462
2. R.D. Abbott, G.W. Ross, H. Petrovitch, C.M. Tanner, D.G. Davis, and K.H. Masaki Bowel movement frequency in late-life and incidental Lewy bodies Mov Disord 22 2007 1581 1586
3. S. Bardien, S. Lesage, A. Brice, and J. Carr Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease Parkinsonism Relat Disord 17 2011 501 508
4. H.W. Berendse, J. Booij, C.M. Francot, P.L. Bergmans, R. Hijman, and J.C. Stoof Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell Ann Neurol 50 2001 34 41
5. A. Bloch, A. Probst, H. Bissig, H. Adams, and M. Tolnay Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects Neuropathol Appl Neurobiol 32 2006 284 295
6. N.I. Bohnen, S. Gedela, P. Herath, G.M. Constantine, and R.Y. Moore Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity Neurosci Lett 447 2008 12 16
7. N.I. Bohnen, S. Gedela, H. Kuwabara, G.M. Constantine, C.A. Mathis, and S.A. Studenski Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease J Neurol 254 2007 84 90
8. N.I. Bohnen, M.L. Muller, V. Kotagal, R.A. Koeppe, M.A. Kilbourn, and R.L. Albin Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease Brain 133 2010 1747 1754
9. H. Braak, R.A. de Vos, J. Bohl, and K. Del Tredici Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology Neurosci Lett 396 2006 67 72
10. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211
11. S. Braune, M. Reinhardt, R. Schnitzer, A. Riedel, and C.H. Lucking Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy Neurology 53 1999 1020 1025
12. K.R. Chaudhuri, D.G. Healy, and A.H. Schapira Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurol 5 2006 235 245
13. H.F. Chiu, Y.K. Wing, L.C. Lam, S.W. Li, C.M. Lum, and T. Leung Sleep-related injury in the elderly - an epidemiological study in Hong Kong Sleep 23 2000 513 517
14. R. de la Fuente-Fernandez, M. Schulzer, L. Kuramoto, J. Cragg, N. Ramachandiran, and W.L. Au Age-specific progression of nigrostriatal dysfunction in Parkinson's disease Ann Neurol 69 2011 803 810
15. R.L. Doty Olfaction in Parkinson's disease Parkinsonism Relat Disord 13 Suppl. 3 2007 S225 S228
16. R.L. Doty, D.A. Deems, and S. Stellar Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration Neurology 38 1988 1237 1244
17. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
18. A. Gaenslen, I. Swid, I. Liepelt-Scarfone, J. Godau, and D. Berg The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease Mov Disord 26 2011 653 658
19. J.F. Gagnon, R.B. Postuma, S. Mazza, J. Doyon, and J. Montplaisir Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases Lancet Neurol 5 2006 424 432
20. T. Gasser, J. Hardy, and Y. Mizuno Milestones in PD genetics Mov Disord 26 2011 1042 1048
21. C.H. Hawkes, B.C. Shephard, and S.E. Daniel Olfactory dysfunction in Parkinson's disease J Neurol Neurosurg Psychiatry 62 1997 436 446
22. D.G. Healy, M. Falchi, S.S. O'Sullivan, V. Bonifati, A. Durr, and S. Bressman Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study Lancet Neurol 7 2008 583 590
23. M.A. Hely, J.G. Morris, W.G. Reid, and R. Trafficante Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years Mov Disord 20 2005 190 199
24. M.A. Hely, W.G. Reid, M.A. Adena, G.M. Halliday, and J.G. Morris The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years Mov Disord 23 2008 837 844
25. O. Hornykiewicz Biochemical aspects of Parkinson's disease Neurology 51 1998 S2 S9
26. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
27. M.M. Hulihan, L. Ishihara-Paul, J. Kachergus, L. Warren, R. Amouri, and R. Elango LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study Lancet Neurol 7 2008 591 594
28. A. Iranzo, F. Lomena, H. Stockner, F. Valldeoriola, I. Vilaseca, and M. Salamero Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected] Lancet Neurol 9 2010 1070 1077
29. A. Iranzo, J.L. Molinuevo, J. Santamaria, M. Serradell, M.J. Marti, and F. Valldeoriola Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study Lancet Neurol 5 2006 572 577
30. T. Lebouvier, M. Neunlist, S. Bruley des Varannes, E. Coron, A. Drouard, and J.M. N'Guyen Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms PLoS One 5 2010 e12728
31. S. Lesage, P. Ibanez, E. Lohmann, P. Pollak, F. Tison, and M. Tazir G2019S LRRK2 mutation in French and North African families with Parkinson's disease Ann Neurol 58 2005 784 787
32. S.Y. Lim, S.H. Fox, and A.E. Lang Overview of the extranigral aspects of Parkinson disease Arch Neurol 66 2009 167 172
33. K. Marek, R. Innis, C. van Dyck, B. Fussell, M. Early, and S. Eberly [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression Neurology 57 2001 2089 2094
34. W.G. Meissner, M. Frasier, T. Gasser, C.G. Goetz, A. Lozano, and P. Piccini Priorities in Parkinson's disease research Nat Rev Drug Discov 10 2011 377 393
35. A. Mirelman, T. Gurevich, N. Giladi, A. Bar-Shira, A. Orr-Urtreger, and J.M. Hausdorff Gait alterations in healthy carriers of the LRRK2 G2019S mutation Ann Neurol 69 2011 193 197
36. T. Miyamoto, M. Miyamoto, Y. Inoue, Y. Usui, K. Suzuki, and K. Hirata Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder Neurology 67 2006 2236 2238
37. E.B. Montgomery Jr., K.B. Baker, K. Lyons, and W.C. Koller Abnormal performance on the PD test battery by asymptomatic first-degree relatives Neurology 52 1999 757 762
38. P.K. Morrish, J.S. Rakshi, D.L. Bailey, G.V. Sawle, and D.J. Brooks Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET J Neurol Neurosurg Psychiatry 64 1998 314 319
39. C. Murphy, C.R. Schubert, K.J. Cruickshanks, B.E. Klein, R. Klein, and D.M. Nondahl Prevalence of olfactory impairment in older adults JAMA 288 2002 2307 2312
40. R. Nandhagopal, E. Mak, M. Schulzer, J. McKenzie, S. McCormick, and V. Sossi Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study Neurology 71 2008 1790 1795
41. G. Peppas, V.G. Alexiou, E. Mourtzoukou, and M.E. Falagas Epidemiology of constipation in Europe and Oceania: a systematic review BMC Gastroenterol 8 2008 5
42. H. Petrovitch, R.D. Abbott, G.W. Ross, J. Nelson, K.H. Masaki, and C.M. Tanner Bowel movement frequency in late-life and substantia nigra neuron density at death Mov Disord 24 2009 371 376
43. M.M. Ponsen, D. Stoffers, J. Booij, B.L. van Eck-Smit, E. Wolters, and H.W. Berendse Idiopathic hyposmia as a preclinical sign of Parkinson's disease Ann Neurol 56 2004 173 181
44. M.M. Ponsen, D. Stoffers, E. Wolters, J. Booij, and H.W. Berendse Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease J Neurol Neurosurg Psychiatry 81 2010 396 399
45. R.B. Postuma, A.E. Lang, J. Massicotte-Marquez, and J. Montplaisir Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder Neurology 66 2006 845 851
46. R. Savica, W.A. Rocca, and J.E. Ahlskog When does Parkinson disease start? Arch Neurol 67 2010 798 801
47. C.H. Schenck, S.R. Bundlie, and M.W. Mahowald Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder Neurology 46 1996 388 393
48. C.H. Schenck, S.R. Bundlie, and M.W. Mahowald REM behavior disorder (RBD): delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep Sleep 26 2003 A316
49. M.B. Stern, and A. Siderowf Parkinson's at risk syndrome: can Parkinson's disease be predicted? Mov Disord 25 Suppl. 1 2010 S89 S93
50. K. Stiasny-Kolster, Y. Doerr, J.C. Moller, H. Hoffken, T.M. Behr, and W.H. Oertel Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT Brain 128 2005 126 137
51. M.M. Vennemann, T. Hummel, and K. Berger The association between smoking and smell and taste impairment in the general population J Neurol 255 2008 1121 1126
52. J. Winkler, R. Ehret, T. Buttner, U. Dillmann, W. Fogel, and M. Sabolek Parkinson's disease risk score: moving to a premotor diagnosis J Neurol 258 2011 S311 S315
53. M. Yoshita, J. Taki, K. Yokoyama, M. Noguchi-Shinohara, Y. Matsumoto, and K. Nakajima Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD Neurology 66 2006 1850 1854
54. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, and S. Lincoln Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607